Adherence to interferon β-1a therapy using an electronic self-injector in multiple sclerosis: a multicentre, single-arm, observational, phase IV study

BACKGROUND: In a multicentre, single-arm, observational, phase IV study, we evaluated 24-week treatment adherence of relapsing multiple sclerosis (RMS) patients using an electronic auto-injection device (RebiSmart(®)) for subcutaneous injection of interferon (IFN) β-1a. METHODS: A total of 162 adult...

Descripción completa

Detalles Bibliográficos
Autores principales: Devonshire, Virginia A., Feinstein, Anthony, Moriarty, Patrick
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4782351/
https://www.ncbi.nlm.nih.gov/pubmed/26951043
http://dx.doi.org/10.1186/s13104-016-1948-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4782351/
https://www.ncbi.nlm.nih.gov/pubmed/26951043
http://dx.doi.org/10.1186/s13104-016-1948-z

Ejemplares similares